Interestingly, we observed that the highest frequency of relapse was developed by MICA-129Val/Val patients also after chemotherapeutic treatment (Figure 2B) suggesting that MICA polymorphism impacts on MM relapse. The gene discussed is MICA; the disease is Miyoshi myopathy.